More opioid users getting treatment since Medicaid expansion

August 17, 2018 by Steven Reinberg, Healthday Reporter

(HealthDay)—The expansion of Medicaid that came along with the Affordable Care Act has made it easier for some opioid users to get treatment, new research suggests.

In a study of nearly 12 million Medicaid patients, researchers found that while the number of prescriptions for painkillers decreased slightly, prescriptions for buprenorphine (Buprenex), a drug to treat addiction, and naloxone (Narcan), which is used to reverse an , rose significantly.

"Getting a Medicaid card has enabled a lot of people to get into doctors' offices and get for their addiction," said lead researcher Brendan Saloner. He's an assistant professor of health policy and management at Johns Hopkins Bloomberg School of Public Health in Baltimore.

"People who were uninsured before Medicaid were less able to go to a private doctor to get a prescription for buprenorphine and naloxone. They relied more on the public safety net or paid cash," Saloner said.

The new findings aren't what opponents of Medicaid expansion predicted. They argued that with more poor people receiving Medicaid, the number of would increase, making the opioid crisis worse.

Instead, making medical care more accessible allowed more opioid users to get treatment, Saloner said.

Nor did prescriptions for opioids rise, proving fears that cheap painkillers would create more addicts were unfounded, he said. Opioid prescription rates didn't change significantly.

"My hope is that Medicaid expansion is going to bring more people into the treated population," Saloner said.

Seventeen states still are fighting expanded Medicaid. And it's in many of these states, including Tennessee, Louisiana and Florida, where the has hit hardest, Saloner said.

He said expanded Medicaid doesn't solve the crisis, but it is an essential part of helping opioid addicts get treatment.

"It's more complicated than just expanding Medicaid," Saloner said.

For the study, Saloner and his colleagues looked at the prescribing of opioids and drugs to treat addiction in five states.

They collected data on 11.9 million people who filled two or more opioid prescriptions during at least one year between 2010 and 2015. The numbers came from three states that expanded Medicaid: California, Maryland and Washington—and two states that didn't: Florida and Georgia.

Researchers noted that because only five states were studied, their findings may not be applicable elsewhere. They added that factors other than Medicaid expansion might explain them.

Their study found that in 2010, before Medicaid expansion, about 70 patients per 100,000 filled prescriptions for buprenorphine with naloxone, and nearly 5,300 per 100,000 filled prescriptions for opioids.

By 2015, prescriptions for buprenorphine with naloxone increased nearly 13 percent in expansion states, compared to non-expansion states.

But compared to non-expansion states, for opioids did not change much in Medicaid expansion states, the researchers found.

"One of the most fundamental issues in resolving the opioid crisis is the profound treatment gap that's present among adults and adolescents," said Dr. Harshal Kirane, director of addiction services at Staten Island University Hospital in New York City.

Only 1 in 10 adults who wants treatment gets it, he said. Getting more patients treated with expanded Medicaid "is really encouraging," said Kirane, who wasn't involved with the study.

The report was published online Aug. 17 in the journal JAMA Network Open.

Explore further: Medicaid expansion leads to greater access to diabetes medications

More information: Brendan Saloner, Ph.D., assistant professor, health policy and management, Johns Hopkins Bloomberg School of Public Health, Baltimore; Harshal Kirane, M.D., director, addiction services, Staten Island University Hospital, New York City; Aug. 17, 2018, JAMA Network Open, online.

For more about opioids, visit the U.S. National Institute on Drug Abuse.

Related Stories

Medicaid expansion leads to greater access to diabetes medications

August 6, 2018
Prescriptions for diabetes medications increased in the first two years after states expanded eligibility for Medicaid as part of the Affordable Care Act, compared to states that didn't expand Medicaid.

Medicaid expansion linked to increased prescribing of buprenorphine for opioid use disorder treatment

March 16, 2017
States where Medicaid coverage was expanded under the Affordable Care Act have had a significant increase in prescribing of buprenorphine—a medication that plays an important role in addressing the opioid epidemic, reports ...

Medicaid expansion states see rise in coverage for low income adults with substance use disorders

August 14, 2018
The percentage of low-income Americans with substance use disorders who were uninsured declined more sharply in states that chose to expand Medicaid under the Affordable Care Act versus states that did not, according to a ...

Increased coverage in states with medicaid expansion

July 23, 2018
(HealthDay)—Coverage rates and access to care are significantly higher in states with Medicaid expansion, compared with non-expansion states, according to a study published in the July issue of Health Affairs.

Disparities in opioid abuse treatment increased among Medicaid recipients, study finds

June 25, 2018
The number of Medicaid recipients receiving medication to treat opioid abuse increased sharply in the years after approval of a new drug, but the increase was smaller in poorer counties and areas with larger populations of ...

In Medicaid patients, high opioid doses and concurrent sedative use are risk factors for fatal opioid overdose

July 12, 2018
Among Medicaid recipients taking prescription opioids, high opioid doses and concurrent treatment with benzodiazepine sedatives are among the key, potentially modifiable risk factors for fatal overdose, reports a study in ...

Recommended for you

Drug overdose epidemic goes far beyond opioids, requires new policies

November 7, 2018
Most government-funded initiatives to address the overdose epidemic in the United States have targeted opioids specifically and have neglected other drugs that are increasingly implicated in overdoses, such as cocaine and ...

Zebrafish larvae help in search for appetite suppressants

November 2, 2018
Researchers at the University of Zurich and Harvard University have developed a new strategy in the search for psychoactive drugs. By analyzing the behavior of larval zebrafish, they can filter out substances with unwanted ...

FDA OKs powerful opioid pill as alternative to IV painkiller

November 2, 2018
U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals.

Amphetamine-related hospitalizations surged between 2003 and 2015

November 2, 2018
An analysis conducted by Hennepin Healthcare, University of Minnesota School of Public Health and University of Michigan researchers shows amphetamine-related hospitalizations increased more than 270 percent from 2008 to ...

Cocaine-fentanyl overdoses underscore need for more 'test strips' and rapid response

November 1, 2018
Penn Medicine emergency department physicians are calling for more readily available testing strips to identify the presence of fentanyl in patients experiencing a drug overdose, and a rapid, coordinated response among health ...

Combination drug targeting opioid system may help relieve symptoms of major depression

October 29, 2018
Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment. The results of ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.